Savory P J, Rivett A J
Department of Biochemistry, University of Leicester, U.K.
Biochem J. 1993 Jan 1;289 ( Pt 1)(Pt 1):45-8. doi: 10.1042/bj2890045.
The multicatalytic proteinase (MCP) complex is a major nonlysosomal proteinase which plays an important role in non-lysosomal pathways of protein degradation and which has recently been implicated in antigen processing. The mammalian MCP complex is composed of more than 20 different types of polypeptide, but it is not yet clear which of these components are responsible for its proteolytic activities. The complex has at least three distinct types of proteolytic activity. One of these, the so-called 'trypsin-like' activity, which involves cleavage on the carboxy side of basic amino acid residues, can be selectively and completely inhibited by peptidyl arginine aldehydes (such as leupeptin and antipain), and is also the most sensitive to inhibition by thiol-reactive reagents. In the present study N-[ethyl-1-14C]ethylmaleimide has been used to specifically label thiol groups protected by leupeptin binding. The results suggest that one or two polypeptide components within the complex can be protected against modification by N-ethylmaleimide. These components may be responsible for the 'trypsin-like' activity of the complex or may be adjacent to the catalytic component(s) and play an important role in substrate binding.
多催化蛋白酶(MCP)复合体是一种主要的非溶酶体蛋白酶,在蛋白质降解的非溶酶体途径中起重要作用,并且最近被认为与抗原加工有关。哺乳动物的MCP复合体由20多种不同类型的多肽组成,但目前尚不清楚这些成分中哪些负责其蛋白水解活性。该复合体至少有三种不同类型的蛋白水解活性。其中一种,即所谓的“胰蛋白酶样”活性,涉及在碱性氨基酸残基的羧基侧进行切割,可被肽基精氨酸醛(如亮抑酶肽和抗痛素)选择性地完全抑制,并且对硫醇反应性试剂的抑制也最为敏感。在本研究中,N-[乙基-1-14C]乙基马来酰亚胺已被用于特异性标记受亮抑酶肽结合保护的硫醇基团。结果表明,复合体内的一种或两种多肽成分可以免受N-乙基马来酰亚胺的修饰。这些成分可能负责复合体的“胰蛋白酶样”活性,或者可能与催化成分相邻,并在底物结合中起重要作用。